Dental Evolutions Introduces New FDA-Approved Dental Implant System Implanova at Annual AO Meeting in San Diego, CA

Dental Evolutions Inc. introduced the first self-grafting, self-osteomising dental implant system at the Annual Academy of Osseointegration’s Annual Meeting in San Diego, CA on February 18. “After studying, placing and restoring dental implants for more than 25 years, I thought of many improvements and noticed many shortcomings and limitations of existing dental implant systems. They are too expensive, too cumbersome, with too many parts to satisfy different implant cases,” says founder of Dental Evolutions Inc. and inventor of Implanova, Parsa T. Zadeh, DDS, MAGD, FICOI.

The patent pending system is one of a few dental implant systems on the market designed for practical use by dentists of any skill level but also for the convenience and pocketbooks of everyday patients. Key benefits of the Implanova Dental Implant System include:

  1. Smart self-grafting bone management system that mitigates the need for additional grafting and special procedures in cases of inadequate and/or soft bone.
  2. Low insertion torque allowing immediate loading capability and little to no wait time for osseointegration. This allows the implant, abutment and crown to be placed in a single day, skipping the six-month waiting period for implant integration.
  3. Single attachment and screw size that can be used for the majority of clinical conditions. This creates low product costs with savings that can be passed down to consumers.

The Food and Drug Administration (FDA) approved Southern-California-manufactured Implanova in 2015. These tests not only examined various aspects of the products themselves but also validated packaging integrity to maintain sterilisation.

Implanova is now available for sale in the US and Canada.